(lp0
S'Merrimack Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 17 Equities.com - 18 hours ago Merrimack Pharmaceuticals Inc.  traded on unusually high volume on Mar. 17, as the stock lost 3.6% to close at $3.21.Fmr LLC Boosts Stake in Merrimack Pharmaceuticals Inc  - Chaffey BreezeMerrimack Pharmaceuticals  Stock: Gaining On Takeover Rumors - CNA Finance '
p1
aS"Here's Why Merrimack Pharmaceuticals Inc. Fell 47.3% in 2016 Motley Fool - Jan 9, 2017 While 2016 was a rough period for the biotech industry in general, shareholders of Merrimack Pharmaceuticals  had to suffer through an especially brutal period.Merrimack Concludes Strategic Review; Announces Plan to Divest Assets and ... - PR Newswire Merrimack Pharmaceuticals Inc  Stock Soars on Ipsen Deal - Investorplace.com"
p2
aS'Company Update : Merrimack Pharmaceuticals Inc Announces 4Q and ... Smarter Analyst - Mar 1, 2017 Merrimack Pharmaceuticals, Inc. engages in discovering, developing and preparing to commercialize innovative medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer.Merrimack Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 01 - Equities.comMerrimack Pharmaceuticals, Inc.  Files An 8-K Results of ... - Market Exclusive'
p3
aS'Earnings Reaction History: Merrimack Pharmaceuticals Inc, 36.4% Follow-Through ... Nasdaq - Mar 1, 2017 Merrimack Pharmaceuticals Inc  is due to issue its quarterly earnings report in the upcoming extended-hours session.'
p4
aS'Merrimack Pharmaceuticals Inc.: Merrimack Announces Timing of Fourth Quarter ... The Wall Street Transcript - Feb 22, 2017 CAMBRIDGE, Mass., Feb. 22, 2017 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc.  today announced that the company will host its Fourth Quarter 2016 investor conference call and webcast at 8:30 a.m.Merrimack Pharmaceuticals, Inc.  Scheduled to Post Earnings on Thursday - The Cerbat GemHot Stock Update: Merrimack Pharmaceuticals, Inc.  - HugoPress'
p5
aS'Merrimack Pharmaceuticals Inc.  Plunges 5.26% on March 07 Equities.com - Mar 7, 2017 Merrimack Pharmaceuticals Inc.  had a rough trading day for Tuesday March 07 as shares tumbled 5.26%, or a loss of $-0.17 per share, to close at $3.06.Merrimack Pharmaceuticals, Inc. : Important Trade and Target Levels To Watch - Post AnalystMerrimack Pharmaceuticals Inc  Receives Consensus Recommendation of Buy ... - Chaffey Breeze'
p6
aS'What Type of Consensus Opinions Analysts hold about Merrimack Pharmaceuticals ... Hot Stocks Point - Mar 17, 2017 Merrimack Pharmaceuticals, Inc.  stock price ended its day with gain 3.74% and finalized at the price of $3.33.'
p7
aS'Merrimack Pharmaceuticals, Inc.  Is Making A Strong Argument Through Its ... NY Stock News - Mar 17, 2017 The technicals for Merrimack Pharmaceuticals, Inc.  has spoken via its technical chart and the message is loud and clear.'
p8
aS'Stock Returns: Sinovac Biotech Ltd.  is Beating Merrimack ... CML News - Mar 16, 2017 This is a snapshot to compare the stock returns for Merrimack Pharmaceuticals Inc  versus Sinovac Biotech Ltd.'
p9
aS'Sell-side is Weighing in on Merrimack Pharmaceuticals, Inc.  Earnings Aiken Advocate - Mar 15, 2017 Wall Street analysts have a current quarter EPS estimate of $-0.05 on shares of Merrimack Pharmaceuticals, Inc. .'
p10
a.